In addition, colonoscopy and biopsies were performed before and after treatment to assess the expression of vasoactive intestinal peptide (VIP), E neuropeptide and substance P (SP), which appears to function in the brain-gut axis, causing abnormal mucosal increase in patients with IBS. The gene discussed is VIP; the disease is irritable bowel syndrome.